View in EDS

SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC.

Saved in:
Bibliographic Details
Title: SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC.
Authors: Peters S; Oncology Department, Lausanne University and CHUV, Lausanne, Switzerland., Hochmair M; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute for Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria., Arbour KC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rodriguez LP; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain., Reck M; Department of Thoracic Oncology, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Grosshansdorf, Germany., Leal T; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., R Lindsay C; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Shun L; Shangai Lung Cancer Centre, Shanghai Chest Hospital, School of Medicine, Shangai Jiaotong University, Shanghai, China., William WN; Grupo Oncoclínicas, São Paulo, Brazil., Spira AI; Virginia Cancer Specialists, Fairfax, VA, USA., Sabari JK; Perlmutter Cancer Centre, NYU Langone Health, New York, NY, USA., Henning Grønberg B; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Nishio M; Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Burns TF; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Colombus, OH, USA., Girard N; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France.; UVSQ, Paris Saclay University, Versailles, France., Capuzzo F; Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Merced A; Eli Lilly and Company, Indianapolis, IN, USA., Fasnacht N; Eli Lilly and Company, Indianapolis, IN, USA., Visseren-Grul C; Eli Lilly and Company, Indianapolis, IN, USA., Negrao MV; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Source: Future oncology (London, England) [Future Oncol] 2026 Apr; Vol. 22 (9), pp. 1073-1082. Date of Electronic Publication: 2026 Apr 06.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41940628
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Peters+S%22">Peters S</searchLink>; Oncology Department, Lausanne University and CHUV, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hochmair+M%22">Hochmair M</searchLink>; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute for Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Arbour+KC%22">Arbour KC</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+LP%22">Rodriguez LP</searchLink>; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Reck+M%22">Reck M</searchLink>; Department of Thoracic Oncology, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Grosshansdorf, Germany.<br /><searchLink fieldCode="AU" term="%22Leal+T%22">Leal T</searchLink>; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22R+Lindsay+C%22">R Lindsay C</searchLink>; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Shun+L%22">Shun L</searchLink>; Shangai Lung Cancer Centre, Shanghai Chest Hospital, School of Medicine, Shangai Jiaotong University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22William+WN%22">William WN</searchLink>; Grupo Oncoclínicas, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Spira+AI%22">Spira AI</searchLink>; Virginia Cancer Specialists, Fairfax, VA, USA.<br /><searchLink fieldCode="AU" term="%22Sabari+JK%22">Sabari JK</searchLink>; Perlmutter Cancer Centre, NYU Langone Health, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Henning+Grønberg+B%22">Henning Grønberg B</searchLink>; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Nishio+M%22">Nishio M</searchLink>; Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Burns+TF%22">Burns TF</searchLink>; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Colombus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Girard+N%22">Girard N</searchLink>; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France.; UVSQ, Paris Saclay University, Versailles, France.<br /><searchLink fieldCode="AU" term="%22Capuzzo+F%22">Capuzzo F</searchLink>; Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Merced+A%22">Merced A</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Fasnacht+N%22">Fasnacht N</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Visseren-Grul+C%22">Visseren-Grul C</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Negrao+MV%22">Negrao MV</searchLink>; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2026 Apr; Vol. 22 (9), pp. 1073-1082. <i>Date of Electronic Publication: </i>2026 Apr 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial Protocol; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41940628
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14796694.2026.2651961
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1073
    Titles:
      – TitleFull: SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Peters S
      – PersonEntity:
          Name:
            NameFull: Hochmair M
      – PersonEntity:
          Name:
            NameFull: Arbour KC
      – PersonEntity:
          Name:
            NameFull: Rodriguez LP
      – PersonEntity:
          Name:
            NameFull: Reck M
      – PersonEntity:
          Name:
            NameFull: Leal T
      – PersonEntity:
          Name:
            NameFull: R Lindsay C
      – PersonEntity:
          Name:
            NameFull: Shun L
      – PersonEntity:
          Name:
            NameFull: William WN
      – PersonEntity:
          Name:
            NameFull: Spira AI
      – PersonEntity:
          Name:
            NameFull: Sabari JK
      – PersonEntity:
          Name:
            NameFull: Henning Grønberg B
      – PersonEntity:
          Name:
            NameFull: Nishio M
      – PersonEntity:
          Name:
            NameFull: Burns TF
      – PersonEntity:
          Name:
            NameFull: Girard N
      – PersonEntity:
          Name:
            NameFull: Capuzzo F
      – PersonEntity:
          Name:
            NameFull: Merced A
      – PersonEntity:
          Name:
            NameFull: Fasnacht N
      – PersonEntity:
          Name:
            NameFull: Visseren-Grul C
      – PersonEntity:
          Name:
            NameFull: Negrao MV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1